Collegium Pharmaceutical Inc (COLL)

Fixed asset turnover

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Revenue (ttm)	US$ in thousands	459,924	438,505	430,531	422,636	400,720	314,280	280,041	251,774	255,854	301,783	299,168	291,446	281,134	286,592	361,135	441,180	518,290	515,321	504,149	494,269
Property, plant and equipment	US$ in thousands	15,983	16,645	18,040	18,879	19,521	19,744	19,965	20,202	19,491	19,629	19,555	19,760	18,988	17,746	15,156	13,145	11,854	11,579	10,367	9,962
Fixed asset turnover		28.78	26.34	23.87	22.39	20.53	15.92	14.03	12.46	13.13	15.37	15.30	14.75	14.81	16.15	23.83	33.56	43.72	44.50	48.63	49.62

December 31, 2023 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $459,924K ÷ $15,983K
= 28.78

Fixed asset turnover is a financial ratio that measures how efficiently a company is utilizing its fixed assets to generate revenue. A higher fixed asset turnover indicates that the company is effectively using its fixed assets to generate sales.

Based on the data provided for Collegium Pharmaceutical Inc, the fixed asset turnover has been showing a consistent increase over the past 8 quarters. In Q4 2022, the company had a fixed asset turnover of 13.51, which has steadily increased to 35.46 in Q4 2023. This upward trend indicates that Collegium Pharmaceutical Inc has been able to generate more revenue per dollar of fixed assets invested, reflecting improved efficiency in utilizing its fixed assets.

The significant improvement in fixed asset turnover over the quarters suggests that Collegium Pharmaceutical Inc has been effectively managing and leveraging its fixed assets to drive sales growth. This could be attributed to factors such as increased productivity, better asset utilization, and effective capital investments.

Overall, the consistent increase in fixed asset turnover for Collegium Pharmaceutical Inc is a positive indicator of the company's operational efficiency and effective management of its fixed assets to drive revenue generation.